Tonix Pharmaceuticals Holding (TNXP) Accumulated Depreciation & Amortization (2023 - 2025)
Historic Accumulated Depreciation & Amortization for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $5.5 million.
- Tonix Pharmaceuticals Holding's Accumulated Depreciation & Amortization rose 5372.22% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 5372.22%. This contributed to the annual value of $4.1 million for FY2024, which is 2359.19% down from last year.
- As of Q3 2025, Tonix Pharmaceuticals Holding's Accumulated Depreciation & Amortization stood at $5.5 million, which was up 5372.22% from $5.1 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Accumulated Depreciation & Amortization registered a high of $6.3 million during Q1 2024, and its lowest value of $2.5 million during Q1 2023.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $4.4 million (2023), whereas its average is $4.4 million.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Accumulated Depreciation & Amortization skyrocketed by 14878.24% in 2024 and then plummeted by 2753.39% in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Accumulated Depreciation & Amortization stood at $5.4 million in 2023, then decreased by 23.59% to $4.1 million in 2024, then surged by 35.07% to $5.5 million in 2025.
- Its last three reported values are $5.5 million in Q3 2025, $5.1 million for Q2 2025, and $4.6 million during Q1 2025.